Ann: ATC listed as important option for HIV sufferers, page-2

"In June of 2010, the AIDS Treatment Activist Coalition (ATAC) and European AIDS Trials Group (EATG) sent an open letter to Susan Cox, PhD, Chief Scientific Officer of Avexa, Nathan Droma, Chair of Avexa and Stephen Kerr, the Company’s Board Secretary that was published on TheBody.com requesting that Avexa reconsider their decision to stop the development of ATC due to the critical need for this drug. "

http://www.hivplusmag.com/research/...itive-people-need-hiv-drug-still-not-approved


I find this very interesting reading